These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The past, present and future of antiviral drug discovery. Littler E. IDrugs; 2004 Dec; 7(12):1104-12. PubMed ID: 15599804 [Abstract] [Full Text] [Related]
23. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F. Wang XS, Tang H, Golbraikh A, Tropsha A. J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978 [Abstract] [Full Text] [Related]
25. QSAR modeling based on structure-information for properties of interest in human health. Hall LH, Hall LM. SAR QSAR Environ Res; 2005 May; 16(1-2):13-41. PubMed ID: 15844441 [Abstract] [Full Text] [Related]
28. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase. Sun J, Cai S, Mei H, Li J, Yan N, Wang Q, Lin Z, Huo D. Chem Biol Drug Des; 2010 Sep 01; 76(3):245-54. PubMed ID: 20626407 [Abstract] [Full Text] [Related]
29. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. Marrero-Ponce Y. J Chem Inf Comput Sci; 2004 Sep 01; 44(6):2010-26. PubMed ID: 15554670 [Abstract] [Full Text] [Related]
39. On the nature, evolution and future of quantitative structure-activity relationships (QSAR) in toxicology. Veith GD. SAR QSAR Environ Res; 2004 Apr 22; 15(5-6):323-30. PubMed ID: 15669692 [Abstract] [Full Text] [Related]